FT14 Jul 2015 07:42
Alent acquisition catalysed by demerger: Ademerger often presages the disappearance of one or both offshoots. The agreed £1.35 billion purchase of Alent, a speciality chemicals group cracked from the precursor that was industrial group Cookson, lends support to that theory. The takeover by Platform Speciality Products, a vehicle of prolific acquirer Martin Franklin, will expose Alent’s non-identical twin Vesuvius to renewed takeover speculation. Quiet activist Cevian has tendered its 22% of Alent for Platform shares. The offer values the equity and debt of Alent, whose products include fancy solder for mobile phone circuit boards, at 13.9 times trailing earnings, compared with a recent average of 10 times. The only investors who could legitimately be worried by the level of the bid would therefore be shareholders in U.S.-listed Platform. They can expect to hear talk of tax losses and synergies with other purchased companies. The paradox is that would-be consolidators such as Mr Davis and Mr Franklin could end up building new conglomerates through special purpose acquisition vehicles such as X2 and Platform. It is reasonable to ask whether these will create more value than the out-of-favour conglomerates from whose offshoots they may be partly composed.